PeopleBio, Inc. (KOSDAQ:304840)
South Korea · Delayed Price · Currency is KRW 561.00
-9.00 (-1.58%)
At close: Jul 31, 2026
PeopleBio Market Cap
PeopleBio has a market cap or net worth of 13.61 billion as of August 12, 2026. Its market cap has decreased by -73.43% in one year.
Market Cap
13.61B
Enterprise Value
24.03B
Revenue
2.87B
Ranking
n/a
PE Ratio
n/a
Stock Price
561.00
ChartMarket Cap Chart
Since October 19, 2020, PeopleBio's market cap has decreased from 127.63B to 13.61B, a decrease of -89.34%. That is a compound annual growth rate of -32.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 13.61B | -39.86% |
| Dec 30, 2025 | 22.63B | -64.95% |
| Dec 30, 2024 | 64.57B | -0.15% |
| Dec 28, 2023 | 64.67B | -65.14% |
| Dec 29, 2022 | 185.49B | 1.48% |
| Dec 30, 2021 | 182.78B | -36.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3billion | 193.48B |
| GENINUS | 85.48B |
| Cytogen | 79.13B |
| Protia | 65.69B |
| Inventera | 61.67B |
| GC Medical Science | 60.01B |
| HLB Panagene | 50.35B |
| Seoulin Bioscience | 41.54B |